Impact of Serum 25(OH) Vitamin D Level on Mortality in Patients with COVID-19 in Turkey

Overview

Journal J Nutr Health Aging

Specialties Geriatrics
Nutritional Sciences

Date 2021 Jan 25

PMID 33491033

Citations 48

Authors

S Karahan

F Katkat

Affiliations

Soon will be listed here.

Abstract

Background: Because of the lack of sufficient data, we aimed to investigate the role of serum 25(OH) vitamin D level on COVID severity and related mortality.

Methods: This was a retrospective observational study. Data, including sociodemographic features, clinical characteristics, and laboratory data, and 25(OH) vitamin D levels were recorded for each study participant. Patients were stratified into different vitamin D groups; Normal (Serum 25(OH) vitamin D level >30 ng/mL), Vitamin D insufficiency (21-29 ng/mL), and deficiency (<20 ng/mL). The severity of COVID was classified according to the Chinese Clinical Guideline for classification of COVID-19 severity. Mortality data were determined for participants. Univariate and multivariate Logistic regression analysis was performed to determine independent predictors of in-hospital mortality.

Results: Overall, 149 COVID-19 patients (females 45.6%, mean age 63.5 ± 15.3 (range 24-90 years) years) were included. Forty-seven patients (31.5%) had moderate COVID-19, whereas 102 patients (68.5%) had severe-critical COVID-19. The mean 25(OH) vitamin D level was 15.2 ± 10.3 ng/mL. Thirty-four (22.8%) and 103 (69.1%) patients had vitamin D insufficiency and deficiency, respectively. Mean serum 25(OH) vitamin D level was significantly lower in patients with severe-critical COVID-19 compared with moderate COVID-19 (10.1 ± 6.2 vs. 26.3 ± 8.4 ng/mL, respectively, p<0.001). Vitamin D insufficiency was present in 93.1% of the patients with severe-critical COVID-19. Multivariate logistic regression analysis revealed that only lymphocyte count, white blood cell count, serum albumin and, 25(OH) vitamin D level were independent predictors of mortality.

Conclusion: Serum 25(OH) vitamin D was independently associated with mortality in COVID-19 patients.

Citing Articles

Comparison of the role of vitamin D in normal organs and those affected by COVID-19.

Peramaiyan R, Anthony J, Varalakshmi S, Sekar A, Ali E, A A Int J Med Sci. 2025; 22(2):240-251.

PMID: 39781525 PMC: 11704692. DOI: 10.7150/ijms.103260.

Vitamin D: A key player in COVID-19 immunity and lessons from the pandemic to combat immune-evasive variants.

Sabit H, Abdel-Ghany S, Abdallah M, Abul-Maaty O, Khoder A, Shoman N Inflammopharmacology. 2024; 32(6):3631-3652.

PMID: 39406981 PMC: 11550250. DOI: 10.1007/s10787-024-01578-w.

Shedding light on the next pandemic path, from outpatient to ICU, the effect of vitamin D deficiency in the SARS-CoV-2 pandemic.

Celikmen F, Tunaligil V, Keles E, Celikmen D, Sarikaya S Front Nutr. 2024; 10:1268267.

PMID: 38260080 PMC: 10800734. DOI: 10.3389/fnut.2023.1268267.

A systematic review: The relationship of COVID-19 to iron, zinc, and vitamin D.

Alsharif M, Alyousef R, Alturki A, Kofi M J Family Med Prim Care. 2023; 12(10):2392-2400.

PMID: 38074276 PMC: 10706502. DOI: 10.4103/jfmpc.jfmpc_2460_22.

Association between Average Vitamin D Levels and COVID-19 Mortality in 19 European Countries-A Population-Based Study.

Ahmad A, Juber N, Al-Naseri H, Heumann C, Ali R, Oliver T Nutrients. 2023; 15(22).

PMID: 38004213 PMC: 10680994. DOI: 10.3390/nu15224818.

References

Rondanelli M, Miccono A, Lamburghini S, Avanzato I, Riva A, Allegrini P . Self-Care for Common Colds: The Pivotal Role of Vitamin D, Vitamin C, Zinc, and in Three Main Immune Interactive Clusters (Physical Barriers, Innate and Adaptive Immunity) Involved during an Episode of Common Colds-Practical Advice on Dosages and.... Evid Based Complement Alternat Med. 2018; 2018:5813095. PMC: 5949172. DOI: 10.1155/2018/5813095. View

Arihiro S, Nakashima A, Matsuoka M, Suto S, Uchiyama K, Kato T . Randomized Trial of Vitamin D Supplementation to Prevent Seasonal Influenza and Upper Respiratory Infection in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2019; 25(6):1088-1095. PMC: 6499936. DOI: 10.1093/ibd/izy346. View

Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J . Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. J Infect. 2020; 81(2):e16-e25. PMC: 7177098. DOI: 10.1016/j.jinf.2020.04.021. View

Rhodes J, Subramanian S, Laird E, Kenny R . Editorial: low population mortality from COVID-19 in countries south of latitude 35 degrees North supports vitamin D as a factor determining severity. Aliment Pharmacol Ther. 2020; 51(12):1434-1437. PMC: 7264531. DOI: 10.1111/apt.15777. View

Jeffery L, Burke F, Mura M, Zheng Y, Qureshi O, Hewison M . 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol. 2009; 183(9):5458-67. PMC: 2810518. DOI: 10.4049/jimmunol.0803217. View

Holick M . Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol. 2008; 19(2):73-8. PMC: 2665033. DOI: 10.1016/j.annepidem.2007.12.001. View

Marik P, Kory P, Varon J . Does vitamin D status impact mortality from SARS-CoV-2 infection?. Med Drug Discov. 2020; 6:100041. PMC: 7189189. DOI: 10.1016/j.medidd.2020.100041. View

Cantorna M, Snyder L, Lin Y, Yang L . Vitamin D and 1,25(OH)2D regulation of T cells. Nutrients. 2015; 7(4):3011-21. PMC: 4425186. DOI: 10.3390/nu7043011. View

Aygun H . Vitamin D can prevent COVID-19 infection-induced multiple organ damage. Naunyn Schmiedebergs Arch Pharmacol. 2020; 393(7):1157-1160. PMC: 7246956. DOI: 10.1007/s00210-020-01911-4. View

10.

Aranow C . Vitamin D and the immune system. J Investig Med. 2011; 59(6):881-6. PMC: 3166406. DOI: 10.2310/JIM.0b013e31821b8755. View

11.

Liu K, Chen Y, Lin R, Han K . Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients. J Infect. 2020; 80(6):e14-e18. PMC: 7102640. DOI: 10.1016/j.jinf.2020.03.005. View

12.

Martineau A, Jolliffe D, Hooper R, Greenberg L, Aloia J, Bergman P . Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017; 356:i6583. PMC: 5310969. DOI: 10.1136/bmj.i6583. View

13.

Ilie P, Stefanescu S, Smith L . The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality. Aging Clin Exp Res. 2020; 32(7):1195-1198. PMC: 7202265. DOI: 10.1007/s40520-020-01570-8. View

14.

Sharifi A, Vahedi H, Nedjat S, Rafiei H, Hosseinzadeh-Attar M . Effect of single-dose injection of vitamin D on immune cytokines in ulcerative colitis patients: a randomized placebo-controlled trial. APMIS. 2019; 127(10):681-687. DOI: 10.1111/apm.12982. View

15.

Wang B, Li R, Lu Z, Huang Y . Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging (Albany NY). 2020; 12(7):6049-6057. PMC: 7185114. DOI: 10.18632/aging.103000. View

16.

. Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7). Chin Med J (Engl). 2020; 133(9):1087-1095. PMC: 7213636. DOI: 10.1097/CM9.0000000000000819. View

17.

Hastie C, Mackay D, Ho F, Celis-Morales C, Katikireddi S, Niedzwiedz C . Vitamin D concentrations and COVID-19 infection in UK Biobank. Diabetes Metab Syndr. 2020; 14(4):561-565. PMC: 7204679. DOI: 10.1016/j.dsx.2020.04.050. View

18.

Cannell J, Vieth R, Umhau J, Holick M, Grant W, Madronich S . Epidemic influenza and vitamin D. Epidemiol Infect. 2006; 134(6):1129-40. PMC: 2870528. DOI: 10.1017/S0950268806007175. View

19.

Kara M, Ekiz T, Ricci V, Kara O, Chang K, Ozcakar L . 'Scientific Strabismus' or two related pandemics: coronavirus disease and vitamin D deficiency. Br J Nutr. 2020; 124(7):736-741. PMC: 7300194. DOI: 10.1017/S0007114520001749. View

20.

Ye Q, Wang B, Mao J . The pathogenesis and treatment of the `Cytokine Storm' in COVID-19. J Infect. 2020; 80(6):607-613. PMC: 7194613. DOI: 10.1016/j.jinf.2020.03.037. View